Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupernatant as replacement

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 2, 2004, Pages 175-179

  Lampinen, Katja ^a   Peltonen, Seija ^a   Pettilä, Ville ^a   Kaaja, Risto ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cryosupernatant; HUS TTP; Plasma exchange; Postpartum thrombotic microangiopathy

Indexed keywords

ADULT; ANURIA; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER DISEASE; LIVER FUNCTION; OLIGURIA; PLASMAPHERESIS; PRIORITY JOURNAL; PUERPERIUM; SUPERNATANT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; CRYOPRESERVATION; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PLASMA EXCHANGE; PREGNANCY; PUERPERAL DISORDERS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 1242342835     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2003.00306.x     Document Type: Article

References (22)

1. Weiner CP. Thrombotic microangiopathy in pregnancy and the post-partum period. Semin Hematol 1987; 24: 119-29.
2. Ferris TF. Preeclampsia and postpartum renal failure: examples of pregnancy-induced microangiopathy. Am J Obstet Gynecol 1995; 99: 343-7.
3. Coates PTH, Patrick G, Seymour A, Pugsley DJ, Hague W, Disney APS et al. Plasmapheresis in postpartum hemolytic uremic syndrome. Kidney Int 1997; 51: 1317.
4. Sibai BM, Kustermann L, Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: different clinical syndromes or just different names? Curr Opin Nephrol Hypertens 1994; 3: 436-45.
5. Egerman RS, Witlin AG, Friedman SA, Steven A, Sibai BM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy. Review of 11 cases. Am J Obstet Gynecol 1996; 175: 950-6.
6. Ruggenenti P & Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J Nephrol 1998; 11: 300-10.
7. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96: 1223-9.
8. Remuzzi G & Ruggenenti P. The hemolytic uremic syndrome. Kidney Int Suppl 1998; 53: S54-7.
9. Neild GH. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Pathophysiology and treatment. Kidney Int 1998; 53: 45-9.
10. Förster JG, Peltonen S, Kaaja R, Lampinen K, Pettilä V. Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand 2002; 46: 955-8.
11. Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998; 91: 662-8.
12. Harkness DR, Byrnes JJ, Lian EC-Y, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. J Am Med Assoc 1981; 246: 1931-3.
13. Ellis J, Theodossiu C, Schwarzenberger P. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of literature. Am J Med Sci 1999; 318: 190-6.
14. Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol 2000; 109: 496-507.
15. Moake JL & McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989; 87: 3N.
16. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Weinstein MG, Colannina NM et al. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood 1984; 64: 592-8.
17. Kelton JG, Moore J, Santos A, Sheridan D. The detection of a platelet-agglutination factor in thrombotic thrombocytopenic purpura. Ann Intern Med 1984; 101: 589-93.
18. Furlan M & Lämmle B. Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura - new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112-14.
19. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
20. Frangos JA, Moake JL, Nolasco L, Philips MD, McIntire LV. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol 1989; 256: H1635-44.
21. Rock G, Shumak KH, Sutton DM, David MC, Buskard NA, Nair RC. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 1996; 94: 383-6.
22. Byrnes JJ, Moake JL, Klug P, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990; 34: 169-74.